Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/26/2008

,000 54,223 127,633 178,869

Loss from operations (16,981) (9,369) (43,424) (57,288)

Equity in the income

of BioMarin/Genzyme

LLC 5,670 9,366 19,274 30,525

Interest income 3,951 7,383 12,417 25,932

Interest expense (2,957) (4,080) (13,411) (14,243)

Debt conversion

expense -- -- (3,315) --

Income (loss) before

income taxes (10,317) 3,300 (28,459) (15,074)

Provision for income

taxes 74 729 74 729

Net income (loss) $(10,391) $2,571 $(28,533) $(15,803)

Net income (loss)

per share, basic $(0.11) $0.03 $(0.34) $(0.16)

Net income (loss)

per share, diluted $(0.11) $0.03 $(0.34) $(0.16)

Shares used in per

share calculation

-- basic 91,552 96,931 84,582 95,878

Shares used in per

share calculation

-- diluted 91,552 101,193 84,582 95,878

(1) The following is the stock-based compensation expense included in the

respective captions of the consolidated statements of operations

above:

Three Months Ended Year Ended

December 31, December 31,

2006 2007 2006 2007

Stock-based compensation

expense:

Cost of goods sold $-- $162 $-- $578

Research and development 1,364 2,211 4,242 6,978

Selling, general and

administrative 1,727 3,092 5,348 10,727

Total
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. BioMarin to Present at the BioCentury NewsMakers Conference
3. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
4. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... DUBLIN , July 29, 2015 ... ) has announced the addition of the ... to their offering. The Global Biosimilars ... study of the rapidly growing biosimilars market. With ... industry striving to minimize costs, biosimilars are being ...
(Date:7/29/2015)... 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) announced ... be released on Thursday, August 13, 2015, before the ... management will host a conference call to discuss the ... release outlining the financial results and business update will ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and reference ...
(Date:7/29/2015)... CITY , July 29, 2015 /PRNewswire/ - Aeterna ... today announced it has selected an optimized Erk ... milestone in the development of a new class ... MAPK pathway represents a prime target for therapeutic ... antitumor activities and survival benefits for B-Raf and ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... Wis. - Be very afraid when a member of Congress ... is that no one else in the world does it like ... vogue, there are certain things this country does well - and ... rivals and competitors overseas. , ,One of those things is innovation. ...
... shares company secrets. He thinks business meetings can be toxic ... teams to improve the flow of communication, and he thinks ... work. , ,There is a method to Jason Fried's ... at the recent Wisconsin Entrepreneurs' Conference in Milwaukee. , ,The ...
... saw its revenues surge by 86 percent and its ... earnings report issued since it officially became a ... has joined a research collaboration with Lawrence Livermore National ... for cancer treatment. , , First quarter financials , ...
Cached Biology Technology:Changes to U.S. patent law must nurture our culture of innovation 2Changes to U.S. patent law must nurture our culture of innovation 3Changes to U.S. patent law must nurture our culture of innovation 4Visions: Chicago software exec Jason Fried breaks (almost) all the rules 2Visions: Chicago software exec Jason Fried breaks (almost) all the rules 3TomoTherapy reports 86% revenue jump, $131M net loss in Q1 2TomoTherapy reports 86% revenue jump, $131M net loss in Q1 3
(Date:7/23/2015)... July 23, 2015 Research and Markets ... the "Global Outlook of the Biometrics Industry ... The global biometrics market is likely ... commercial applications owing to the uptake of multiple ... transformation that enhances the growth of biometrics in ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
(Date:7/9/2015)... Research and Markets( ... "Biometrics for Banking; Market & Technology Analysis, ... their offering. The adoption for banking ... and the forecast is that by 2020 it ... involved in delivering biometric systems to the banking ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... corn, soybeans and sunflowers into fuel uses much more ... to a new Cornell University and University of California-Berkeley ... using plant biomass for liquid fuel," says David Pimentel, ... are not sustainable." , Pimentel and Tad W. Patzek, ...
... a family of mysterious objects called microcompartments that seem ... discovery was published Aug. 5 in the journal Science. ... are built, and what the pieces look like," said ... and a member of the UCLA-DOE Institute of Genomics ...
... biochemists reveal the first structural details of a family ... present in a variety of bacteria. The discovery was ... is the first look at how microcompartments are built, ... Yeates, UCLA professor of chemistry and biochemistry, and a ...
Cached Biology News:Using the genomic shortcut to predict bacterial behavior 2Field tested: Grasslands won't help buffer climate change as carbon dioxide levels rise 2Field tested: Grasslands won't help buffer climate change as carbon dioxide levels rise 3Nighttime Dying Linked To Sleep Apnea From Brain Cell Loss 2Nighttime Dying Linked To Sleep Apnea From Brain Cell Loss 3